Published by Maryam Cockar on 13th February 2017
(ShareCast News) - AIM-listed Evgen Pharma has signed a services agreement with a consortium of Cheshire-based drug developments firms for its sulforaphane product.
URL: http://www.digitallook.com/dl/news/story/25545066/...